Skip to main content
Top
Published in: Rheumatology International 4/2008

01-02-2008 | Original Article

Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis

Authors: Ozlem Altindag, Ozcan Erel, Neslihan Soran, Hakim Celik, Sahabettin Selek

Published in: Rheumatology International | Issue 4/2008

Login to get access

Abstract

The aim of this study was to evaluate the total antioxidant status (TAS), total oxidative status (TOS) and oxidative stress index (OSI) in patients with postmenopausal osteoporosis. We also investigate the relation between bone mineral density and oxidative/antioxidative parameters. Thirty-nine patients with osteoporosis and 26 healthy controls were included in the study. Plasma TAS, TOS levels were determined by using a novel automated methods. Plasma TOS and OSI value were significantly higher, and plasma TAS level was lower in patients than in healthy controls (P < 0.001 for all). There was a significant negative correlation between OSI and BMD in lumbar and femoral neck region (r = −0.63, P < 0.001; r = 0.40, P = 0.018). The results of this study indicated that increased osteoclastic activity and decreased osteoblastic activity may be associated with an imbalance between oxidant and antioxidant status in postmenopausal osteoporosis. Therefore, supplementation of antioxidant-enriched diet to the therapy might shed light on the development of novel therapeutic strategies for osteoporosis.
Literature
1.
go back to reference Compston JE, Papapoulos SE, Blanchard F (1998) Report on osteoporosis in the European community: current status and recommendations for the future. Osteoporos Int 8:531–534PubMedCrossRef Compston JE, Papapoulos SE, Blanchard F (1998) Report on osteoporosis in the European community: current status and recommendations for the future. Osteoporos Int 8:531–534PubMedCrossRef
2.
go back to reference Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330PubMedCrossRef Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330PubMedCrossRef
3.
go back to reference The European prospective osteoporosis study (EPOS) group (2002) J Bone Miner Res 17:716–724CrossRef The European prospective osteoporosis study (EPOS) group (2002) J Bone Miner Res 17:716–724CrossRef
4.
go back to reference Mueller G, Russell RG (2003) Osteoporosis: pathogenesis and clinical intervention. Biochem Soc Trans 31:462–464PubMedCrossRef Mueller G, Russell RG (2003) Osteoporosis: pathogenesis and clinical intervention. Biochem Soc Trans 31:462–464PubMedCrossRef
5.
go back to reference Nathan CF, Tsunawaki S (1986) Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase. Ciba Found Symp 118:211–230PubMed Nathan CF, Tsunawaki S (1986) Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase. Ciba Found Symp 118:211–230PubMed
6.
go back to reference Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. For the Scientific Advisory Council of the Osteoporosis Society of Canada. CMAJ 167:1–34 Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. For the Scientific Advisory Council of the Osteoporosis Society of Canada. CMAJ 167:1–34
7.
go back to reference Gur A, Sarac AJ, Nas K, Cevik R (2004) The relationship between educational level and bone mineral density in postmenopausal women. BMC Fam Pract 5:18PubMedCrossRef Gur A, Sarac AJ, Nas K, Cevik R (2004) The relationship between educational level and bone mineral density in postmenopausal women. BMC Fam Pract 5:18PubMedCrossRef
9.
go back to reference Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T (1989) The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805–1813PubMedCrossRef Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T (1989) The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805–1813PubMedCrossRef
10.
go back to reference Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT (2004) Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 279:40007–40016PubMedCrossRef Salim A, Nacamuli RP, Morgan EF, Giaccia AJ, Longaker MT (2004) Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 279:40007–40016PubMedCrossRef
11.
go back to reference Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, Meghji S (2003) Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 196:2–8PubMedCrossRef Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, Meghji S (2003) Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 196:2–8PubMedCrossRef
12.
go back to reference Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A (2005) Oxidative stress and reactive oxygen species. Contrib Nephrol 149:240–260PubMedCrossRef Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A (2005) Oxidative stress and reactive oxygen species. Contrib Nephrol 149:240–260PubMedCrossRef
13.
go back to reference Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724PubMedCrossRef Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724PubMedCrossRef
14.
go back to reference Aruoma OI (1996) Characterization of drugs as antioxidant prophylactics. Free Radic Biol Med 20:675–705PubMedCrossRef Aruoma OI (1996) Characterization of drugs as antioxidant prophylactics. Free Radic Biol Med 20:675–705PubMedCrossRef
15.
go back to reference Sontakke AN, Tare RS (2002) A duality in the roles of reactive species with respect to bone metabolism. Clin Chim Acta 318:145–148PubMedCrossRef Sontakke AN, Tare RS (2002) A duality in the roles of reactive species with respect to bone metabolism. Clin Chim Acta 318:145–148PubMedCrossRef
16.
go back to reference Yang S, Madyastha P, Bingel S, Ries W, Key L (2001) A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276:5452–5458PubMedCrossRef Yang S, Madyastha P, Bingel S, Ries W, Key L (2001) A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276:5452–5458PubMedCrossRef
17.
go back to reference Dreher I, Schuetze N, Baur A, Hesse K, Schneider D, Koehrle J, Jakob F (1998) Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun 245:101–107PubMedCrossRef Dreher I, Schuetze N, Baur A, Hesse K, Schneider D, Koehrle J, Jakob F (1998) Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun 245:101–107PubMedCrossRef
18.
go back to reference Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGF-β in osteoclast differentiation and survival. J Cell Sci 113:2445–2453PubMed Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGF-β in osteoclast differentiation and survival. J Cell Sci 113:2445–2453PubMed
19.
go back to reference Varenna M, Binelli L, Zucchi F, Rossi V, Sinigaglia L (2003) Prevalence of osteoporosis and fractures in a migrant population from southern to northern Italy: a cross-sectional, comparative study. Osteoporos Int 14:734–740PubMedCrossRef Varenna M, Binelli L, Zucchi F, Rossi V, Sinigaglia L (2003) Prevalence of osteoporosis and fractures in a migrant population from southern to northern Italy: a cross-sectional, comparative study. Osteoporos Int 14:734–740PubMedCrossRef
20.
go back to reference Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285PubMedCrossRef Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285PubMedCrossRef
21.
go back to reference Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef
22.
go back to reference Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923PubMedCrossRef Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923PubMedCrossRef
23.
go back to reference Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88:1523–1527PubMedCrossRef Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88:1523–1527PubMedCrossRef
24.
go back to reference Bagis S, Tamer L, Sahin G (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25:188–190PubMedCrossRef Bagis S, Tamer L, Sahin G (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25:188–190PubMedCrossRef
25.
go back to reference Yalin S, Bagis S, Polat G, Dogruer N, Cenk Aksit S, Hatungil R, Erdogan C (2005) Is there a role of free oxygen radicals in primary male osteoporosis? Clin Exp Rheumatol 23:689–692PubMed Yalin S, Bagis S, Polat G, Dogruer N, Cenk Aksit S, Hatungil R, Erdogan C (2005) Is there a role of free oxygen radicals in primary male osteoporosis? Clin Exp Rheumatol 23:689–692PubMed
26.
go back to reference Wolf RL, Cauley JA, Pettinger M, Jackson R, Lacroix A, Leboff MS (2005) Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women’s Health Initiative. Am J Clin Nutr 82:581–588PubMed Wolf RL, Cauley JA, Pettinger M, Jackson R, Lacroix A, Leboff MS (2005) Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women’s Health Initiative. Am J Clin Nutr 82:581–588PubMed
27.
go back to reference Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632–639PubMed Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85:632–639PubMed
28.
go back to reference Eghbali-Fatourechi G, Khosla S, Sanal A, Boyle WC, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:121–130CrossRef Eghbali-Fatourechi G, Khosla S, Sanal A, Boyle WC, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:121–130CrossRef
29.
go back to reference Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRef Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRef
30.
go back to reference Vural P, Akgul C, Canbaz M (2005) Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 42:220–223PubMedCrossRef Vural P, Akgul C, Canbaz M (2005) Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 42:220–223PubMedCrossRef
31.
go back to reference Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197:93–100PubMedCrossRef Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197:93–100PubMedCrossRef
32.
go back to reference Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14:129–135PubMedCrossRef Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S (1999) Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14:129–135PubMedCrossRef
33.
go back to reference Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852–859PubMedCrossRef Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852–859PubMedCrossRef
34.
go back to reference Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH (2006) Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 40:1483–1493PubMedCrossRef Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH (2006) Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 40:1483–1493PubMedCrossRef
35.
go back to reference Varanasi SS, Francis RM, Berger CE, Papiha SS, Datta HK (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10:143–149PubMedCrossRef Varanasi SS, Francis RM, Berger CE, Papiha SS, Datta HK (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10:143–149PubMedCrossRef
Metadata
Title
Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis
Authors
Ozlem Altindag
Ozcan Erel
Neslihan Soran
Hakim Celik
Sahabettin Selek
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0452-0

Other articles of this Issue 4/2008

Rheumatology International 4/2008 Go to the issue